Enhanced antitumor efficacy by blocking activation of the phosphatidylinositol 3-kinase/Akt pathway during anti-angiogenesis therapy.
- Published in:
- Cancer Science, 2011, v. 102, n. 8, p. 1469, doi. 10.1111/j.1349-7006.2011.01979.x
- By:
- Publication type:
- Article